Eton Pharmaceuticals (ETON) Payables (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Payables data on file, last reported at $11.0 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 163.4% year-over-year to $11.0 million; the trailing twelve-month figure through Dec 2025 stood at $11.0 million (up 163.4% YoY), and the FY2025 full-year result was $11.0 million, up 163.4% from the prior year.
• Payables slipped to $11.0 million in Q4 2025, from $14.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $14.3 million in Q3 2025 to a low of $1.1 million in Q3 2022.
• A 5-year average of $3.8 million and a median of $2.1 million in 2022 frame the typical range for Payables.
• Across the five-year window, Payables slumped 67.8% in 2022 and jumped 469.25% in 2025, its largest moves.
• Tracing ETON's Payables over 5 years: stood at $1.8 million in 2021, then fell by 0.45% to $1.8 million in 2022, then rose by 4.64% to $1.8 million in 2023, then surged by 125.49% to $4.2 million in 2024, then surged by 163.4% to $11.0 million in 2025.
• Business Quant data shows ETON's Payables at $11.0 million in Q4 2025, $14.3 million in Q3 2025, and $12.1 million in Q2 2025.